TurnSole Announces Regulatory Authority Approval and Subsequent Initiation of a Phase Ib/II Trial to evaluate the efficacy and the safety of TS-020 in acute COVID-19 viral infection in Patients with Severe Infection with Risk of Progression

by NASDAQ Market News March 4, 2021

NASDAQ Market News
Click here to email author

The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019

Ballad Health launches new Niswonger Children’s Network, reinforces world-class healthcare and well-being for women and children

Ads